Pfizer Total Long Term Liabilities 2010-2024 | PFE

Pfizer total long term liabilities for the quarter ending December 31, 2024 were $81.904B, a 8.4% decline year-over-year.

  • Pfizer total long term liabilities for 2024 were $81.904B, a 8.4% decline from 2023.
  • Pfizer total long term liabilities for 2023 were $89.418B, a 51.17% increase from 2022.
  • Pfizer total long term liabilities for 2022 were $59.149B, a 3.58% decline from 2021.

Pfizer Total Long Term Liabilities 2010-2024 | PFE

  • Pfizer total long term liabilities for 2024 were $81.904B, a 8.4% decline from 2023.
  • Pfizer total long term liabilities for 2023 were $89.418B, a 51.17% increase from 2022.
  • Pfizer total long term liabilities for 2022 were $59.149B, a 3.58% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B